Low-dose ATGAM treatment sufficiently reduces total T-cell counts and remains clinically effective in prophylactic and anti-rejection protocols.
作者信息
Ekberg H, Källén R, Schatz H, Persson N H
机构信息
Department of Vascular and Renal Diseases, Lund University, University Hospital, Malmö, Sweden.
出版信息
Transplant Proc. 1995 Dec;27(6):3430-1.
PMID:8540035
Abstract
摘要
Zotero 插件